BRANDI RATLIFF: Open Payments
NPI 1902480643 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 54 payments from 11 companies in 2025. Trend: 2023 $1,372 · 2024 $864 · 2025 $1,145
Food & beverage: $1,130Education: $15
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $216 |
| Ardelyx, Inc. | 10 | $192 |
| ABBVIE INC. | 10 | $176 |
| Janssen Biotech, Inc. | 9 | $160 |
| EVOKE PHARMA, INC. | 3 | $141 |
| KYOWA KIRIN, INC. | 1 | $125 |
| PFIZER INC. | 2 | $47 |
| Gilead Sciences, Inc. | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: FANAPT, IBSRELA, TREMFYA, GIMOTI, LINZESS, SKYRIZI, PREVNAR 20, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
